A2A Pharmaceuticals, Inc. - 31 Mar 2023 Form 4 Insider Report for Biomea Fusion, Inc. (BMEA)

Role
10%+ Owner
Signature
Edward Painter
Issuer symbol
BMEA
Transactions as of
31 Mar 2023
Net transactions value
+$6,250,000
Form type
4
Filing time
06 Apr 2023, 18:43:47 UTC
Previous filing
19 Aug 2022
Next filing
26 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMEA Common Stock Sale $6,250,000 +200,000 +5.1% $31.25 4,100,000 31 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 A total of 200,000 shares were sold at an average price of 31.25 in multiple transactions ranging in price from 30.87 to 31.64